LVW Advisors LLC Takes $218,000 Position in iShares Nasdaq Biotechnology ETF (IBB)

LVW Advisors LLC acquired a new stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) during the 3rd quarter, HoldingsChannel reports. The fund acquired 1,785 shares of the financial services provider’s stock, valued at approximately $218,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Natixis lifted its holdings in shares of iShares Nasdaq Biotechnology ETF by 8.7% in the second quarter. Natixis now owns 1,250,000 shares of the financial services provider’s stock worth $137,275,000 after buying an additional 100,000 shares in the last quarter. PNC Financial Services Group Inc. lifted its holdings in shares of iShares Nasdaq Biotechnology ETF by 0.4% in the second quarter. PNC Financial Services Group Inc. now owns 639,136 shares of the financial services provider’s stock worth $70,190,000 after buying an additional 2,256 shares in the last quarter. Commerzbank Aktiengesellschaft FI lifted its holdings in shares of iShares Nasdaq Biotechnology ETF by 54.0% in the second quarter. Commerzbank Aktiengesellschaft FI now owns 585,506 shares of the financial services provider’s stock worth $64,300,000 after buying an additional 205,200 shares in the last quarter. Main Management LLC lifted its holdings in shares of iShares Nasdaq Biotechnology ETF by 0.8% in the second quarter. Main Management LLC now owns 464,308 shares of the financial services provider’s stock worth $50,990,000 after buying an additional 3,726 shares in the last quarter. Finally, Paloma Partners Management Co lifted its holdings in shares of iShares Nasdaq Biotechnology ETF by 1,643.3% in the second quarter. Paloma Partners Management Co now owns 323,373 shares of the financial services provider’s stock worth $35,513,000 after buying an additional 304,824 shares in the last quarter. 63.62% of the stock is currently owned by institutional investors and hedge funds.

Shares of iShares Nasdaq Biotechnology ETF stock opened at $108.50 on Wednesday. iShares Nasdaq Biotechnology ETF has a 12-month low of $100.22 and a 12-month high of $122.97.

ILLEGAL ACTIVITY NOTICE: This news story was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/11/07/lvw-advisors-llc-takes-218000-position-in-ishares-nasdaq-biotechnology-etf-ibb.html.

iShares Nasdaq Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Further Reading: Stock Symbols, CUSIP and Other Stock Identifiers

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply